Trial Profile
Filtered Trial for Telmisartan 40mg Non-responder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Mar 2014
Price :
$35
*
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Telmisartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 08 Oct 2008 Actual patient number (314) added as reported by ClinicalTrials.gov.
- 08 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.